promising doublets under investigation in clinical trials in 1l intermediate- and high-risk mds
Published 1 year ago • 58 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
3:39
promising agents under investigation for the treatment of mds and ongoing trials in this space
-
3:31
promising treatment options emerging for higher-risk mds & the value of clinical trials
-
3:01
novel promising agents and clinical trials in amyloidosis
-
1:41
novel therapies for high-risk mds
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
1:42
unmet needs in high-risk mds and ongoing trials in the field
-
1:36
clinical trials evaluating novel agents in mds: select-mds-1
-
1:56
promising approaches and clinical trials in mds
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
3:24
novel agents in higher-risk mds
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
3:08
htert reduction by imetelstat correlates with clinical activity in mds
-
2:16
current and future treatment approaches for hr-mds
-
1:19
the promise of precision medicine in mds
-
1:16
state of the art: mds
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
1:38
using mrd as an endpoint in clinical trials
-
2:17
mrd: a promising biomarker in multiple myeloma